Skip to content

Organon OGN Nexplanon — Number of matters involved

Similar metrics at other companies

ESAB logo
ESABNumber of Class Action Lawsuits
$15.71K+11.4%
Match Group logo
MTCHNumber of lawsuits with possible material impact (one or more)
10.0%
Bausch + Lomb logo
BLCOCanada — Number of lawsuits pending
$20.0%
Bausch + Lomb logo
BLCOCA-BC — Number of lawsuits pending
$10.0%
Bausch + Lomb logo
BLCOCA-QC — Number of lawsuits pending
$10.0%
Assured Guaranty logo
AGONon-US — Number of Risks
336

Other financials

Income statement

See full
Revenue$1.5B-3.5%
Gross profit$783.0M-6.9%
Net income$146.0M+67.8%
EPS (diluted)$0.55+66.7%

Balance sheet

See full
Cash & equivalents$1.1B+104%
Total debt$8.6B-4.3%
Total equity$903.0M+66.6%
Total assets$13.0B-1.2%

Cash flow

See full
Operating cash flow$225.0M+200%
CapEx$37.0M+15.6%
Free cash flow$188.0M+337%

Valuation

See full
Market cap$3.53B-59.4%

Profitability

See full
Gross margin52.8%-4.4pp
Net margin8%-12.3pp
FCF margin11.1%-1.3pp

Returns & leverage

See full
Return on equity71.6%
Debt / equity9.5×-7.0×
Current ratio+0.3×

Where this comes from

Reported directly by Organon in its filing.

Tagged under the XBRL concept ogn:LossContingencyMattersInvolvedNumber.

The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Organon's nexplanon — number of matters involved.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Organon's nexplanon — number of matters involved?
Organon (OGN) reported nexplanon — number of matters involved of 1 in Q1 2026.
What does nexplanon — number of matters involved mean?
This metric represents the total count of active legal proceedings or formal disputes associated with the Nexplanon product line. Monitoring this figure helps investors assess the scope of litigation risk and the potential for operational distraction or reputational impact on a key pharmaceutical asset.